1.
Ann Thorac Surg
; 109(6): e439-e440, 2020 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31715152
RESUMO
Anticoagulation with unfractionated heparin is vital to reduce the risk of thromboembolic events during cardiopulmonary bypass and left ventricular assist device placement. However patients with heparin-induced thrombocytopenia are at risk of developing immune-mediated thrombotic events. We describe 2 patients with heparin-induced thrombocytopenia confirmed via serotonin release assay who were successfully treated with plasmapheresis exchange before left ventricular assist device placement.